Diabetic foot syndrome as a possible cardiovascular marker in diabetic patients

Antonino Tuttolomondo1, Carlo Maida1, Antonio Pinto1

  • 1Dipartimento Biomedico di Medicina Interna e Specialistica, U.O.C di Medicina Interna e Cardioangiologia, Università degli Studi di Palermo, Piazza delle Cliniche, No. 2, 90127 Palermo, Italy.

Insights

Diabetic foot ulcers are linked to increased cardiovascular and cerebrovascular events due to inflammatory processes. Understanding these immune inflammatory features may help identify cardiovascular risk in diabetes patients.

Area of Science:

  • Endocrinology
  • Immunology
  • Cardiology

Background:

  • Diabetic foot ulcerations (DFUs) are significant vascular complications of diabetes mellitus.
  • DFUs are associated with high morbidity and mortality, including increased cardiovascular and cerebrovascular events.
  • A complex interplay of inflammatory metabolic disorders affects the cardiovascular system in diabetes.

Purpose of the Study:

  • To review the immune inflammatory features of diabetic foot syndrome (DFS).
  • To explore the potential role of these features as markers of cardiovascular risk in diabetes patients.

Main Methods:

  • Literature review focusing on immune inflammatory markers and the adipovascular axis in diabetes.
  • Analysis of studies investigating plasma levels of inflammatory markers like IL-6, resistin, and adiponectin in diabetic patients with and without foot ulcers.

Main Results:

  • The "adipovascular axis" involves inflammatory markers such as Interleukin-6 (IL-6) and resistin, contributing to cardiovascular risk in type 2 diabetes.
  • In patients with diabetic foot, lower adiponectin and higher IL-6 plasma levels are linked to ulcer pathogenesis via microvascular and inflammatory mechanisms.

Conclusions:

  • Immune inflammatory processes, particularly the adipovascular axis, play a crucial role in the pathogenesis of diabetic foot ulcers.
  • These inflammatory features may serve as valuable markers for assessing cardiovascular risk in individuals with diabetes.

Related Concept Videos

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
704
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.9K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.6K
Assessment of the Cardiovascular System III: Palpation01:27

Assessment of the Cardiovascular System III: Palpation

Palpation involves feeling the body to evaluate texture, size, consistency, and tenderness for assessing cardiovascular health. The following steps are organized in a head-to-toe order:
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above...
1.6K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.7K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
782